Abstract
Normally the body store of iron which is surplus to immediate requirements is regulated somewhere between 0 and 2000 mg, depending on the balance between the amounts of available dietary iron ingested and the individual’s need for iron to replace losses and to provide for growth. In order for iron stores to be increased above 2000 mg, additional iron must gain access to the body. There are two ways in which this can occur — by increased iron absorption or by parenteral iron administration. Absorption may be increased as a result of the ingestion of large amounts of iron over long periods, although it appears difficult to overcome the ability of the intestinal mucosa to regulate the quantity assimilated. At present the most convincing example of oral iron overload in the face of a normal regulatory absorptive mechanism is provided by the black populations of southern Africa, who ingest large amounts of iron in fermented alcoholic beverages [11]. Oral iron overload may also occur when the iron content of the diet is not excessive. In the metabolic disorder idiopathic haemochromatosis there is a failure of the homeostatic mechanism controlling absorption and a state of positive iron balance continues indefinitely so that there is a steady build-up in the iron content of the body [6]. A similar situation occurs in certain chronic refractory anaemias, notably thalassaemia major, and in certain patients with liver disease [16]. Parenteral iron overload is nearly always due to treatment of refractory nonhaemorrhagic anaemias with multiple blood transfusions. There are about 225 mg iron in each unit of blood, and since the body’s ability to excrete unwanted iron is limited, its iron content is increased by this amount.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Barry, M., Flynn, D. M., Letsky, E. A., Risdon, R. A.: Long-term chelation therapy in thalassae-mia major: effect on liver iron concentration, liver histology and clinical progress. Br. Med. J. 1974 II, 16–20
Bezwoda, W. R., Bothwell, T. H., Van der Walt, L. A., Kronheim, S., Pimstone, B. L.: An investigation into gonadal dysfunction in patients with idiopathic hemochromatosis. Clin. Endocrinol. 6, 377–385 (1977)
Bomford, A., Eddleston, A. L. W. F., Kennedy, L. A., Batchelor, J. R., Williams, R.: Histoeompat-ability antigens as markers of abnormal iron metabolism in patients with idiopathic haemochro-matosis and their relatives. Lancet 1977 I, 327–329
Bothwell, T. H., Charlton, R. W.: Dietary iron overload. In: Iron metabolism and its disorders. Kief, H. (ed.), pp. 221–229. Amsterdam: Excerpta Medica 1975
Bothwell, T. H., Charlton, R. W.: Hemochromatosis. In: Diseases of the liver. Schiff, L. (ed.), pp. 971–999. Philadelphia, Toronto: Lippincott 1975
Bothwell, T. H., Finch, C. A.: Iron metabolism. Boston: Little & Brown 1962
Bothwell, T. H., Derman, D., Bezwoda, W. R., Torrance, J. D., Charlton, R. W.: Can iron fortification of flour cause damage to genetic susceptibles (idiopathic haemochromatosis and β-thalassaemia). Hum. Genet. [Suppl.] 1, 131–137 (1978)
Brink, B., Disler, P., Lynch, S., Jacobs, P., Charlton, R., Bothwell, T.: Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis. J. Lab. Clin. Med. 88, 725–731 (1977)
Charlton, R. W., Bothwell, T. H.: Hemochromatosis: dietary and genetic aspects. In: Progress in hematology. Brown, E. B., Moore, C. V. (eds.), Vol. 5, pp. 298–323. New York: Grune & Stratton 1966
Charlton, R. W., Bothwell, T. H.: Iron, ascorbic acid and thalassemia. In: Iron metabolism in thalassemia. Bergsma, D., Cerami, A., Peterson, C. M., Graziano, J. H. (eds.), pp. 63–80. New York: Liss 1976
Charlton, R. W., Bothwell, T. H., Seftel, H. C.: Dietary iron overload. In: Clinics in haematology. Callender, S. T. (ed.), Vol. 2, pp. 383–404. London: Saunders 1973
Cooper, B., Bunn, H. F., Propper, R. D., Nathan, D. G., Rosenthal, D. S., Maloney, W. C.: Treatment of iron overload in adults with continuous parenteral desferrioxamine. Am. J. Med. 63, 958–966 (1977)
Fillet, G., Marsaglia, G.: Idiopathic hemochromatosis (IH). Abnormality in RBC transport of iron by the reticuloendothelial system (RES). Blood 46, 1007 (1975)
Finch, C. A., Deubelbeiss, K., Cook, J. D., Eschbach, J. W., Harker, L. A., Funk, D. D., Marsaglia, G., Hillman, R. S., Slichter, S., Adamson, J. W., Ganzoni, A., Giblett, E. R.: Ferrokinetics in man. Medicine 49, 17–53 (1970)
Goldberg, L., Smith, J. P., Martin, L. E.: The effects of intensive and prolonged administration of iron parenterally in animals. Br. J. Exp. Pathol. 38, 297–311 (1957)
Grace, N. D., Powell, L. W.: Iron storage disorders in the liver. Gastroenterology 64, 1257–1283 (1974)
Grady, R. W.: The development of new drugs for use in iron chelation therapy. In: Iron metabolism in thalassemia. Bergsma, D., Derami, A., Peterson, C. M., Graziano, J. H. (eds.), pp. 161–175. New York: Liss 1976
Heinrich, H. C., Gabbe, E. E., Oppitz, K. H., Whang, D. H., Götze, C. B., Schäfer, K. H., Schröter, W., Pfau, A. A.: Absorption of inorganic and food iron in children with heterozygous and homozygous beta-thalassemia. Z. Kinderheilkd. 115, 1–22 (1973)
Henke, J., Ungar, W.: HLA-antigens in idiopathic haemochromatosis. Preliminary report. Z. Immunitätsforsch. Immunobiol. 154, 41–43 (1978)
Henry, W. L., Nienhuis, A. W.: Possible adverse effects of ascorbic acid on cardiac function in patients with myocardial iron overload. Blood 5, 993 (1977)
Hershko, C., Graham, G., Bates, G. W., Rachmilewitz, E. A.: Nonspecific serum iron in thalassemia-abnormal serum iron fraction of potential toxicity. Br. J. Haematol. 40, 255–263 (1978)
Hunt, J., Richards, R. J., Harwood, R., Jacobs, A.: The effect of desferrioxamine on fibroblasts and collagen formation in cell cultures. Br. J. Haematol. 41, 69–76 (1979)
Hussain, M. A. M., Flynn, D. M., Green, N., Hoffbrand, A. V.: Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine. Lancet 1977 I, 977–979
Hyman, C. B., Landing, B., Alfin-Slater, R., Kozak, L., Weitzman, J., Ortega, J. A.: dl-Alpha-tocopherol, iron, and lipofuscin in thalassemia. Ann. N.Y. Acad. Sci. 232, 211–220 (1974)
Lipschitz, D. A., Bothwell, T. H., Seftel, H. C., Wapnick, A. A., Charlton, R. W.: The role of ascorbic acid in the metabolism of storage iron. Br. J. Haematol. 20, 155–163 (1971)
MacDonald, R. A.: Hemochromatosis and hemosiderosis. Springfield, Ill.: Thomas 1964
MacPhail, A. P., Simon, M. O., Torrance, J. D., Charlton, R. W., Bothwell, T. H., Isaacson, C.: Changing patterns of dietary iron overload in black South Africans. Am. J. Clin. Nutr. (in press)
Modell, B.: Total management of thalassaemia major. Arch. Dis. Child. 52, 489–500 (1977)
Peters, T. J., Seymour, C. A.: Acid hydrolase activities and lysosomal integrity in liver biopsies from patients with iron overload. Clin. Sci. Molec. Med. 50, 15–1% (1976)
Pippard, M. J., Callender, S. T., Weatherall, D. J.: Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias. Clin. Sci. Mol. Med. 54, 99–106 (1978)
Rowe, J. W., Wands, J. R., Mezey, E., Waterbury, L. A., Wright, J. R., Tobin, J., Andres, R.: Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred. Medicine 56, 197–211 (1977)
Seymour, C. A., Peters, T. J.: Organelle pathology in primary and secondary haemochromatosis with special reference to lysosomal changes. Br. J. Haematol. 40, 239–253 (1978)
Simon, M., Bourel, M.: Hérédité de l’hémochromatose idiopathique: démonstration de la transmission récessive et mise en évidence du gène responsable porté par le chromosome 6. Gastroenterol. Clin. Biol. 2, 573–577 (1978)
Simon, M., Bourel, M., Fauchet, R., Genetet, B.: Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 17, 332–334 (1976)
Trump, B. F., Valigorsky, J. M., Arstila, A. U., Mergner, W. J., Kinney, T. D.: The relationship of intracellular pathways of iron metabolism to cellular iron overload and the iron storage diseases. Am. J. Pathol. 72, 295–324 (1973)
Wapnick, A. A., Lynch, S. R., Krawitz, P., Seftel, H. C., Charlton, R. W., Bothwell, T. H.: Effects of iron overload on ascorbic acid metabolism. Br. Med. J. 1968 III, 704–707
Weatherall, D. J., Pippard, M. J., Callender, S. T.: Iron loading and thalassemia — experimental successes and practical realities. N. Engl. J. Med. 297, 445–446 (1977)
Wheby, M. S., Umpierre, G.: Effect of transferrin saturation on iron absorption in man. N. Engl. J. Med. 271, 1391–1395 (1964)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Bothwell, T.H., Charlton, R.W. (1979). Current Problems of Iron Overload. In: Gross, R., Hellriegel, KP. (eds) Strategies in Clinical Hematology. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 69. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81371-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-81371-9_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81373-3
Online ISBN: 978-3-642-81371-9
eBook Packages: Springer Book Archive